首页> International journal of hematology> Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.

Targeting myeloma-osteoclast interaction with Vγ9Vδ2 T cells.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qu,Cui

第一单位： Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.

作者： Qu,Cui ^[1] ; Hironobu,Shibata ^[2] ; Asuka,Oda ^[1] ; Hiroe,Amou ^[1] ; Ayako,Nakano ^[1] ; Kenichiro,Yata ^[1] ; Masahiro,Hiasa ^[3] ; Keiichiro,Watanabe ^[4] ; Shingen,Nakamura ^[1] ; Hirokazu,Miki ^[1] ; Takeshi,Harada ^[1] ; Shiro,Fujii ^[1] ; Kumiko,Kagawa ^[1] ; Kyoko,Takeuchi ^[1] ; Shuji,Ozaki ^[2] ; Toshio,Matsumoto ^[1] ; Masahiro,Abe ^[5]

作者单位： Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan. ^[1] Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.;Division of Internal Medicine, Tokushima Prefectural Central Hospital, Tokushima, Japan. ^[2] Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.;Department of Biomaterials and Bioengineering, University of Tokushima Graduate School of Oral Sciences, Tokushima, Japan. ^[3] Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.;Department of Orthodontics and Dentofacial Orthopedics, University of Tokushima Graduate School of Oral Sciences, Tokushima, Japan. ^[4] Department of Medicine and Bioregulatory Sciences, University of Tokushima Graduate School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan. masabe@clin.med.tokushima-u.ac.jp. ^[5]